Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Roldán Deamicis A"'
Autor:
Santiago Madera, Franco Izzo, María F. Chervo, Agustina Dupont, Violeta A. Chiauzzi, Sofia Bruni, Ezequiel Petrillo, Sharon S. Merin, Mara De Martino, Diego Montero, Claudio Levit, Gabriel Lebersztein, Fabiana Anfuso, Agustina Roldán Deamicis, María F. Mercogliano, Cecilia J. Proietti, Roxana Schillaci, Patricia V. Elizalde, Rosalía I. Cordo Russo
Publikováno v:
Cell Death and Disease, Vol 14, Iss 12, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/f97153e8a240450a80194174d2482fd7
Autor:
Santiago Madera, Franco Izzo, María F. Chervo, Agustina Dupont, Violeta A. Chiauzzi, Sofia Bruni, Ezequiel Petrillo, Sharon S. Merin, Mara De Martino, Diego Montero, Claudio Levit, Gabriel Lebersztein, Fabiana Anfuso, Agustina Roldán Deamicis, María F. Mercogliano, Cecilia J. Proietti, Roxana Schillaci, Patricia V. Elizalde, Rosalía I. Cordo Russo
Publikováno v:
Cell Death and Disease, Vol 13, Iss 5, Pp 1-14 (2022)
Abstract Triple-negative breast cancer (TNBC) is clinically defined by the absence of estrogen and progesterone receptors and the lack of membrane overexpression or gene amplification of receptor tyrosine kinase ErbB-2/HER2. Due to TNBC heterogeneity
Externí odkaz:
https://doaj.org/article/c5cf687b8b084672a59b0ffb44e8ef9e
Autor:
Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.
Publikováno v:
Cell Death & Disease; Dec2023, Vol. 14 Issue 12, p1-3, 3p
Autor:
Martine Roudier, Siyuan Zheng, Yiji Liao, Zhao Zhang, Douglas Pechacek, Kevin Vu, Teresa L. Johnson-Pais, Eloise Dray, Robin J. Leach, Mei Yang, Agustina Roldán Deamicis, Cecilia J. Proietti, Hung-Ming Lam, Bárbara de la Peña Avalos, Pooja Yadav, Juyeong Hong, Richard De La Rosa, Ji Hoon Lee, G. Pablo Guzmán, Anthony Sisk, Jose M. Garcia, Manjeet K. Rao, Jessica Scheirer, Kexin Xu, Patricia V. Elizalde
Publikováno v:
Science Advances
Down-regulation of HMBOX1 via METTL3-catalyzed m6A causes genomic instability driven by telomere dysfunction in cancer.
The role of RNA methylation on N6-adenosine (m6A) in cancer has been acknowledged, but the underlying mechanisms remain obscu
The role of RNA methylation on N6-adenosine (m6A) in cancer has been acknowledged, but the underlying mechanisms remain obscu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de1d12b63f714b8b85b364d3b979e19
https://doi.org/10.1126/sciadv.abg7073
https://doi.org/10.1126/sciadv.abg7073
Autor:
Pablo Guzmán, Juan Carlos Roa, Silvina Figurelli, Agustina Roldán Deamicis, Rosalia Ines Cordo Russo, Leandro Venturutti, Mauro E. Cenciarini, Felipe G. Gercovich, Agustina Dupont, María F. Chervo, Violeta A. Chiauzzi, Santiago Madera, Sabrina Barchuk, Daniel Lopez Della Vecchia, Cecilia Jazmín Proietti Anastasi, Patricia V. Elizalde, Matías G. Pereyra, Roxana Schillaci, Sandra L. Ares, Ernesto Gil Deza
Publikováno v:
Journal of the Endocrine Society
Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd8efa62e66cc6c4af7c9a0885b65b4
http://europepmc.org/articles/PMC7208765
http://europepmc.org/articles/PMC7208765
Autor:
Madera, Santiago, Chiauzzi, Violeta Alicia, Chervo, María Florencia, Pereyra, Matías G., Venturutti, Leandro, Roldán Deamicis, Agustina, Dupont, Agustina, Guzmán, Pablo, Roa, Juan Carlos, Cenciarini, Mauro Ezequiel, Barchuk, Sabrina, Figurelli, Silvina, Lopez Della Vecchia, Daniel Edgardo, Ares, Sandra, Proietti Anastasi, Cecilia Jazmín, Deza, Ernesto Gil, Gercovich, Felipe G, Schillaci, Roxana, Elizalde, Patricia Virginia, Cordo Russo, Rosalia Ines
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7df4f518f04ff72fee07fa62c80680c9
https://academic.oup.com/jes/article/doi/10.1210/jendso/bvaa046.1037/5833795
https://academic.oup.com/jes/article/doi/10.1210/jendso/bvaa046.1037/5833795
Autor:
Cecilia J. Proietti, Sandra L. Ares, Ernesto Gil Deza, Pablo Guzmán, Juan Carlos Roa, Agustina Dupont, Agustina Roldán Deamicis, Roxana Schillaci, Rosalia Ines Cordo Russo, Sabrina Barchuk, Franco Izzo, Felipe G. Gercovich, Matías G. Pereyra, Leandro Venturutti, Fabiana Anfuso, Patricia V. Elizalde, Eduardo Cortese, Teresa Castiglioni, Violeta A. Chiauzzi, Mauro E. Cenciarini, Santiago Madera, Gabriel Lebersztein, Silvina Figurelli, Claudio Levit, María F. Chervo, Daniel Lopez Della Vecchia
Publikováno v:
Hormonescancer. 11(5-6)
The hormone receptor-positive (estrogen and/or progesterone receptor (PR)-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that includes luminal A-like (LumA-like) and luminal B-like (LumB-like) subtypes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9fe7a71af0ab81b933a7eaec0593ad
https://pubmed.ncbi.nlm.nih.gov/32632815
https://pubmed.ncbi.nlm.nih.gov/32632815
Autor:
Nicolás Bellora, Tim H-M Huang, Agustina Roldán Deamicis, Rosalia Ines Cordo Russo, Patricia V. Elizalde, María F. Chervo, Santiago Madera, Micaela Parra, Cecilia J. Proietti, Kohzoh Mitsuya, Violeta A. Chiauzzi, Ezequiel Petrillo, Roxana Schillaci
Publikováno v:
Journal of the Endocrine Society
Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and lack membrane overexpression or gene amplification of ErbB-2 tyrosine kinase receptor. Transcriptome a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6214d504665f4b5ed28e55aa5c7d20e
http://europepmc.org/articles/PMC8089239
http://europepmc.org/articles/PMC8089239
Autor:
Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.
Publikováno v:
Cell Death & Disease; May2022, Vol. 13 Issue 5, p1-14, 14p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.